Second, shRNA knockdown or CRISPR/Cas9 KO of ORP5 or ORP8 mislocalized PtdSer and KRAS from the PM and decreased the extent of KRAS PM clustering in human pancreatic, breast and colorectal cancer cells. This evidence concerns the gene OSBPL8 and colorectal cancer.